Search

everythinglearnresearchcommunity

for

Search:↓

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

The document concludes that corticosteroids effectively treat vasculitis allergica in over 90% of cases, with long-term kidney issues being the main adverse outcome.

Examining scalp tissue under a microscope helps diagnose and understand hair loss diseases.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

MSCs and their exosomes may speed up skin wound healing but need more research for consistent use.

A specific genetic change is linked to mental disorders, intellectual disability, and possibly autoimmune disease in a family.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

Using old drugs for new uses can help treat rare immune deficiencies.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Mnemonics help improve memory in dermatology by up to 50%.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Alopecia areata is caused by the immune system attacking hair follicles.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Vitiligo is linked to autoimmune diseases and hearing issues, so hearing tests are recommended for patients.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Japanese vitiligo patients and their families often have other autoimmune diseases.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.